title: Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum.
abstract: Clinical studies have demonstrated that the antidepressant efficacy of Hypericum perforatum extract is comparable to that of classic antidepressants, such as imipramine. The role played by its components, particularly hypericin and hyperforin, has been examined in different experimental models of depression. The present study was carried out in order to verify the hypothesis that hyperforin is the main active antidepressant component. For this purpose we evaluated the activity of a dry extract from a subspecies of H. perforatum, H. perforatum spp. angustifolium, which has a higher hyperforin content than H. perforatum perforatum, in a series of experimental models of depression. The models used are based on the development of hyporeactivity to aversive stimuli induced by unavoidable stress exposure in rats. The extract of H. perforatum angustifolium presented an efficacy that was similar to that obtained with a treatment with imipramine or H. perforatum perforatum. Furthermore, in the models used the H. perforatum angustifolium extract was active at doses eight times lower than those necessary to produce a comparable activity with H. perforatum extract.
authors.affiliation: Department of Scienze del Farmaco, University of Sassari, Sassari, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Usai
authors.forename: B
authors.initials: B
authors.lastname: Leggio
authors.forename: S
authors.initials: S
authors.lastname: Grappi
authors.forename: G
authors.initials: G
authors.lastname: Nanni
authors.forename: C
authors.initials: C
authors.lastname: Gambarana
authors.forename: P
authors.initials: P
authors.lastname: Tolu
authors.forename: D
authors.initials: D
authors.lastname: Giachetti
authors.forename: M G
authors.initials: MG
authors.lastname: De Montis
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001643:Bridged Bicyclo Compounds; D003863:Depression / Q000188:drug therapy* / Q000523:psychology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D020902:Hypericum; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D010696:Phloroglucinol / Q000031:analogs & derivatives; D008517:Phytotherapy; D010936:Plant Extracts / Q000494:pharmacology / Q000627:therapeutic use; D010946:Plants, Medicinal; D051381:Rats; D017207:Rats, Sprague-Dawley; D013315:Stress, Psychological / Q000150:complications*; D013729:Terpenes / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000928:Antidepressive Agents; D001643:Bridged Bicyclo Compounds; D010936:Plant Extracts; D013729:Terpenes; D010696:Phloroglucinol; D007099:Imipramine; C001654:hyperforin